Skip to main content
HairCited

Minoxidil for Female Pattern Hair Loss

A

Based on 111 studies (8 meta-analyses, 20 RCTs) with 37,800 total participants. 84/111 studies show positive effects.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

The Bottom Line

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Effect: None None

Population: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Effect: None None

Population: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Effect: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo Effect: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo Effect: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Effect: None None

Key Statistics

111

Studies

37800

Participants

Positive

A

Grade

Referenced Papers

Australian prescriber 2025 2 citations
Annals of dermatology 2025
SAGE open medical … 2024 3 citations
Drugs 2023 221 citations
Anais brasileiros de … 2023 29 citations
Journal of cosmetic … 2023 3 citations
The Journal of … 2022 170 citations
Faculty reviews 2022 44 citations
Journal of cosmetic … 2022 7 citations
Journal of the … 2021 42 citations
American journal of … 2020 127 citations
International journal of … 2020 58 citations
Indian dermatology online … 2020 31 citations
Actas dermo-sifiliograficas 2019 5 citations
International journal of … 2018 129 citations
Australian journal of … 2018 8 citations
JAMA dermatology 2017 121 citations
The Cochrane database … 2016 18 citations
The Medical clinics … 2015 66 citations
World journal of … 2015 62 citations
Seminars in cutaneous … 2015 20 citations
Clinical obstetrics and … 2015 9 citations
Current problems in … 2015 8 citations
Skin therapy letter 2014 29 citations
Journal of drugs … 2014 26 citations
Dermatologic clinics 2013 78 citations
International journal of … 2013 61 citations
Indian journal of … 2013 16 citations
International journal of … 2013
The Cochrane database … 2012 15 citations
Skinmed 2012 5 citations
The Australasian journal … 2011 44 citations
Seminars in cutaneous … 2009 4 citations
American family physician 2009
Journal of the … 2008 290 citations
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
Journal of the … 2005 247 citations
The British journal … 2005 205 citations
The journal of … 2003 102 citations
Clinical and experimental … 2002 61 citations
Therapeutische Umschau. Revue … 2002 4 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

topical:
2-5% solution, twice daily

Upper limit: 5% topical solution

Dosages Studied in Research

Dosage Duration Effect N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

Best taken: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Reported Side Effects

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Known Interactions

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Tolerable upper intake: 5% topical solution

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Minoxidil help with Female Pattern Hair Loss?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Female Pattern Hair Loss management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Female Pattern Hair Loss?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Female Pattern Hair Loss?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.